下载文档原格式
左炔诺孕酮宫内缓释系统治疗子宫内膜异位症疗效观察寇淑敏【摘要】目的:探究左炔诺孕酮宫内缓释系统在子宫内膜异位症治疗中的临床应用效果.方法:对我院收治的36例放置左炔诺孕酮宫内缓释系统的子宫内膜异位症患者的临床资料进行回顾性分析,观察治疗效果.结果:放置左炔诺孕酮宫内缓释系统后患者痛经评分、血清CA125水平及VEGF水平较治疗前均显著下降,子宫内膜明显变薄,子宫、卵巢囊肿体积显著变小,月经模式显著改善,放置前后数据存在统计学差异(P<0.05).结论:子宫内膜异位症治疗中,运用左炔诺孕酮宫内缓释系统可有效缓解患者疼痛症状,缓释持续时间较长且安全性较高,值得临床应用推广.【期刊名称】《药品评价》【年(卷),期】2018(015)016【总页数】3页(P40-42)【关键词】子宫内膜异位症;左炔诺孕酮宫内缓释系统;疗效【作者】寇淑敏【作者单位】河南省西平县中医院妇产科,河南西平 463900【正文语种】中文【中图分类】R984子宫内膜异位症在妇科疾病中较为常见，由具有活性的内膜细胞种植在子宫内膜以外的位置形成，多发生于生育年龄的女性，绝经后异位病灶可逐渐萎缩退化[1]。
临床中针对年龄较大且无生育要求的患者可采取根治性手术及子宫切除术进行治疗，对于年龄尚轻且有生育要求的患者可予以药物治疗或进行病灶挖除，但保守性术后仍存在复发风险，药物治疗可有效缓解症状，也应注意不良反应，且停药后症状可能复现[2,3]。
本次研究给予36例子宫内膜异位症患者左炔诺孕酮宫内缓释系统治疗，成效显著，现报道如下。
1 资料与方法1.1 一般资料选取我院2016年9月—2017年9月收治的确诊为子宫内膜异位症患者36例，所有患者均接受放置左炔诺孕酮宫内缓释系统治疗。
患者年龄在34～46岁之间，平均(39.54±1.23)岁；孕次1～5次，平均(3.42±1.53)次；流产0～3次，平均(1.41±1.25)次；R-AFS分期Ⅱ期9例，Ⅲ期23例，Ⅳ期4例。
左炔诺孕酮宫内释放系统联合黄体酮胶囊治疗宫腔镜下子宫内膜息肉切除术后患者的效果张启欣① 裴璐璐① 【摘要】 目的：探讨左炔诺孕酮宫内释放系统联合黄体酮胶囊治疗宫腔镜下子宫内膜息肉切除术（TCRP）后患者的效果。
方法：选择2020年7月—2022年3月扬州市妇幼保健院收治的88例TCRP后患者，按照随机数表法分为两组，各44例。
对照组给予左炔诺孕酮宫内释放系统治疗，观察组在对照组基础上加用黄体酮胶囊治疗，比较两组临床疗效、不同时间点血红蛋白水平、子宫内膜容受性、子宫内膜组织表达水平及复发率。
结果：观察组总有效率高于对照组，差异有统计学意义（P<0.05）。
治疗1个月经周期后、治疗结束后，两组血红蛋白水平均高于治疗前，且观察组高于对照组，差异有统计学意义（P<0.05）。
治疗结束后，两组子宫内膜厚度、子宫体积小于治疗前，且观察组小于对照组，差异有统计学意义（P<0.05）。
治疗结束后，观察组酪氨酸激酶生长因子受体（C-kit）、C-kit配体干细胞因子（SCF）、乙醛脱氢酶1（ALDH1）低于对照组，差异有统计学意义（P<0.05）。
随访期间，观察组复发率为2.44%，低于对照组的5.88%，但两组间比较，差异无统计学意义（χ2=0.028，P=0.868）。
结论：左炔诺孕酮宫内释放系统联合黄体酮胶囊在TCRP后患者中具有良好疗效，不仅能够有效控制机体血红蛋白水平，改善临床症状，还能够有效调节子宫内膜组织表达水平，改善子宫内膜容受性，且不增加术后复发率。
【关键词】 左炔诺孕酮宫内释放系统 黄体酮胶囊 子宫内膜息肉 血红蛋白 子宫内膜容受性 doi：10.14033/ki.cfmr.2023.27.033 文献标识码 B 文章编号 1674-6805（2023）27-0135-05 Effects of Levonorgestrel Intrauterine Release System Combined with Progesterone Capsules in the Treatment of Patients after Hysteroscopic Transcervical Resection of Endometrial Polyps/ZHANG Qixin, PEI Lulu. //Chinese and Foreign Medical Research, 2023, 21(27): 135-139 [Abstract] Objective: To explore the effect of Levonorgestrel Intrauterine Release System combined with Progesterone Capsules in the treatment of patients after hysteroscopic transcervical resection of endometrial polyps (TCRP). Method: A total of 88 patients with TCRP treated in Yangzhou Maternal and Child Health Hospital from July 2020 to March 2022 were selected and divided into two groups according to random number table method, with 44 patients in each group. The control group was treated with Levonorgestrel Intrauterine Release System, and the observation group was treated with Progesterone Capsules on the basis of the control group. The clinical efficacy, hemoglobin level at different time points, endometrial receptivity, endometrial tissue expression level and recurrence rate were compared between the two groups. Result: The total effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). After treatment for 1 menstrual cycle and after treatment, hemoglobin level in the two groups was higher than those before treatment, and observation group were higher than those of control group, the differences were statistically significant (P<0.05). After treatment, endometrial thickness and uterine volume in the two groups were less than those before treatment, and the observation group were less than those in the control group, and the differences were statistically significant (P<0.05). After treatment, the tyrosine kinase growth factor receptor (C-kit), C-kit ligand stem cell factor (SCF) and acetaldehyde dehydrogenase 1 (ALDH1) in the two groups were lower than those before treatment, and the observation group were lower than those in the control group, the differences were statistically significant (P<0.05). During the follow-up period, the recurrence rate in the observation group was 2.44%, which was lower than 5.88% in the control group, but there was no significant difference between the two groups (χ2=0.028, P=0.868). Conclusion: Levonorgestrel Intrauterine Release System combined with Progesterone Capsules has a good effect in patients after TCRP, which can not only effectively control the level of hemoglobin in the body and improve clinical symptoms, but also effectively regulate the expression level of endometrial tissue, improve endometrial receptivity, and do not increase the postoperative recurrence rate. [Key words] Levonorgestrel Intrauterine Release System Progesterone Capsules Endometrial polyps Hemoglobin Endometrial receptivity First-author's address: Yangzhou Maternal and Child Health Hospital, Yangzhou 225000, China①扬州市妇幼保健院 江苏 扬州 225000 子宫内膜息肉发病率为7.8%~34.9%，该疾病主要以阴道不规则出血、月经量增加、经期延长等为主要表现，若不及时予以治疗，随着症状的加重，将会导致不孕的发生[1]。
左炔诺孕酮宫内缓释系统联合宫腔形宫内节育器治疗子宫腺肌病临床效果观察王宝俊;周琦;邹运【期刊名称】《临床军医杂志》【年(卷),期】2022(50)5【摘要】目的观察左炔诺孕酮宫内缓释系统(LNG-IUS)联合宫腔形宫内节育器治疗子宫腺肌病的临床效果。
方法回顾性分析首都医科大学附属北京妇产医院自2018年1月至2020年7月收治的接受LNG-IUS治疗的84例子宫腺肌病患者的临床资料。
根据是否联合应用宫腔形宫内节育器,将患者分为LNG-IUS组(放置1枚LNG-IUS,n=63)和联合组(放置1枚LNG-IUS+宫腔形宫内节育器,n=21)。
对患者进行随访,观察治疗效果及节育器结局。
结果两组患者子宫体积、有无既往LNG-IUS下移/脱落史、宫深比较,差异均有统计学意义(P<0.05);节育器下移/脱落率、痛经及月经量多改善率比较,差异均无统计学意义(P>0.05)。
结论对于子宫大、宫腔过深的子宫腺肌病患者,LNG-IUS联合宫腔形宫内节育器无法降低节育器的下移/脱落率,临床上暂不推荐联合应用。
【总页数】4页(P510-513)【作者】王宝俊;周琦;邹运【作者单位】首都医科大学附属北京妇产医院/北京妇幼保健院妇科;首都医科大学附属北京妇产医院/北京妇幼保健院产三科【正文语种】中文【中图分类】R711.71【相关文献】1.宫腔镜子宫内膜切除、左炔诺孕酮宫内缓释系统联合治疗子宫腺肌病的疗效观察2.宫腔镜子宫内膜切除术联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病疗效观察3.宫腔镜子宫内膜切除联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察4.左炔诺孕酮宫内缓释系统联合固定式宫内节育器治疗子宫腺肌病的临床研究5.宫腔镜子宫内膜息肉电切术(TCRP)联合左炔诺孕酮宫内缓释系统(曼月乐宫内节育器)治疗子宫内膜息肉(EMP)的临床效果探讨因版权原因，仅展示原文概要，查看原文内容请购买。
TCRP联合左炔诺孕酮缓释系统治疗子宫内膜息肉效果观察梁荣丽;罗宋;黄小静【摘要】目的观察宫腔镜子宫内膜息肉电切术(TCRP)联合左炔诺孕酮缓释系统(LNG-IUS)治疗子宫内膜息肉(EMP)的临床疗效及安全性.方法选取佛山市三水区妇幼保健院妇科2014年1月至2015年7月收治且行宫腔镜子宫内膜息肉电切术的EMP患者80例,按随机数表法分为观察组(n=40)和对照组(n=40),对照组单纯给予TRCP治疗,观察组在TRCP术后1周在宫腔内放置曼月乐宫内节育器;随访2年,观察两组患者子宫内膜厚度、月经量、雌孕激素、血红蛋白水平、不良反应与复发情况.结果术后6、12、24个月,观察组患者的子宫内膜厚度分别为(5.11±0.86)mm、(4.17±0.65)mm、(3.04±0.51)mm,对照组分别为(6.54±1.13)mm、(5.26±0.98)mm、(4.33±0.79)mm,差异均具有统计学意义(P<0.05);术后6、12、24个月,观察组患者的月经失血图评分(PBAC)分别为(44.03±11.54)分、(36.78±8.49)分、(32.27±5.61)分,对照组分别为(85.24±17.35)分、(54.18±12.93)分、(44.62±10.17)分,差异均具有统计学意义(P<0.05);术后6、12、24个月,观察组患者的血红蛋白水平分别为(94.37±7.25)g/L、(117.68±7.38)g/L、(126.17±10.82)g/L,对照组分别为(90.01±5.54)g/L、(99.27±7.82)g/L、(108.64±9.28)g/L,差异均具有统计学意义(P<0.05);两组患者术后12个月雌激素(E2)、孕激素(P)水平与术前比较均有升高,但差异无统计学意义(P>0.05);观察组术后乳房胀痛、经期延长发生率与对照组比较,差异均无统计学意义(P>0.05);观察组一周后出现8例阴道点滴状流血,对照组出现1例,均未给予特殊治疗,6个月后自然恢复;观察组术后2年内均无复发,对照组术后两年内出现11例复发,差异具有统计学意义(P<0.05).结论 TCRP联合左炔诺孕酮缓释系统能够有效降低子宫内膜厚度,减少月经量,降低复发率,值得临床推广应用.%Objective To observe the clinical efficacy and safety of transcervical resection of polyps(TCRP) combined with levonorgestrel sustained release system (LNG-IUS) in the treatment of endometrial polyps (EMP). Methods A total of 80 cases of endometrial polyps treated by TCRP from January 2014 to July 2015 in Foshan Sans-hui District Maternal and Child Health Hospital were selected and divided into the observation group(n=40)and the con-trol group(n=40)according to random number table method.The control group was treated with TRCP alone,and the observation group applied LNG-IUS after 1 month of TRCP.The follow-up period was 2 years.The thickness of the en-dometrium, menstrual blood, estrogen (E2), progesterone (P), hemoglobin, adverse reactions and recurrence were ob-served.Results After the operation of 6,12 and 24 months,the thickness of endometrium in the observation group wererespectively(5.11±0.86)mm,(4.17±0.65)mm,(3.04±0.51)mm v ersus corresponding(6.54±1.13)mm,(5.26±0.98)mm and(4.33±0.79)mm in the control group(P<0.05);the Pictorial Blood Loss AssessmentChart(PBAC)scores in the ob-servation groupwere(44.03±11.54)points,(36.78±8.49)points and(32.27±5.61)points respectively,which were signifi-cantly lower thancorresponding(85.24±17.35),(54.18±12.93)points and(44.62±10.17)points in the control group(P<0.05);the levels of hemoglobin in the observation group were(94.37±7.25)g/L,(117.68±7.38)g/L,(126.17±10.82)g/L, respectively,which were significantly higherthan(90.01±5.54)g/L,(99.27±7.82)g/L,(108.64±9.28)g/L in the controlgroup(P<0.05).The levels of E2 and P at 12 months after operation in both groups were significantly higher than those before operation(P>0.05).There was no significant difference in the incidence of postoperative breast tenderness and menstruation between the two groups(P>0.05).One week after the treatment,there were 8 cases of vaginal drip bleed-ing in the observation group and 1 case in the control group, which all recovered spontaneously without special treat-ment after 6 months;there was no recurrence within 2 years in the observation group and 11 cases of recurrence in the control group(P<0.05).Conclusion TCRP combined with LNG-IUS effectively reduce the thickness of endometrium, menstrual flow and the recurrence rate,which is worthy of clinical promotion.【期刊名称】《海南医学》【年(卷),期】2018(029)008【总页数】4页(P1093-1096)【关键词】宫腔镜子宫内膜息肉电切术;左炔诺孕酮缓释系统;子宫内膜息肉;临床疗效【作者】梁荣丽;罗宋;黄小静【作者单位】佛山市三水区妇幼保健院妇科,广东佛山528100;佛山市三水区妇幼保健院妇科,广东佛山528100;佛山市三水区妇幼保健院妇科,广东佛山528100【正文语种】中文【中图分类】R711.74子宫内膜息肉(endometrial polyps，EMP)是由子宫内膜基底层过度增生引起的突出于宫腔的单个或多个肿物，临床症状主要为阴道不规则流血、经期延长、月经量过多等，严重者可导致不孕症。
宫腹腔镜联合手术治疗子宫切口憩室的疗效观察杨莉【摘要】目的：探究宫腹腔镜联合手术在治疗子宫切口憩室中的应用效果。
方法将我院2014年1～12月收治的子宫切口憩室患者64例随机分为两组，每组各32例。
对照组行阴式手术治疗，观察组给予宫腹腔镜联合修补手术治疗，对比两组治疗效果。
结果观察手术时间长于对照组，差异有统计学意义（P＜0.05）；观察组术中出血量及住院时间与对照组相比，无明显差异（P＞0.05）；观察组子宫憩室修复有效率和经期恢复有效率分别为84.4%、87.5%，对照组分别为87.5%、90.6%，两组相比无明显差异（P＞0.05）。
结论宫腹腔镜联合手术是临床治疗子宫切口憩室的有效方法，应用效果确切，临床治疗需综合考虑和评估患者情况，选择合适的治疗方案，以提高治疗的有效率。
%Objective To explore the effect of application of uterine incision diverticulum treated by laparoscopy combined with surgery.Methods From January to December 2014, 64 cases of patients with uterine incision diverticulum in our hospital were randomly divided into two groups, 32 cases in each group. The control group was treated by vaginal surgery, the treatment group was treated by laparoscopy combines surgery, to compare the curative effect of two groups.Results The operation time of the treatment group was longer than the control group, there was statistically signiifcant differences (P<0.05). To compare the intraoperatve blood soss and hospital stays of the treatment group and the control group, there was no statistically significant difference (P>0.05). The effective rate of repair of uterus diverticulum and effective rate of recovery of menstrual of the treatment group was 84.4%and 87.5%, the control group was 87.55% and 90.65%, to compare them, there was no statistically signiifcant difference (P>0.05).ConclusionThe laparoscopy combines surgery is the effective method of clinic treatment for the uterine incision diverticulum, the application effect is definite, that need the overall consideration and evaluation of the clinical situation, and to choose the appropriate therapeutic schedule, so that improve the effective rate of treatment.【期刊名称】《中国继续医学教育》【年(卷),期】2016(008)017【总页数】2页(P131-132)【关键词】宫腹腔镜;联合;子宫切口憩室【作者】杨莉【作者单位】周口市中心医院妇科，河南周口 466000【正文语种】中文【中图分类】R713子宫切口憩室是剖宫产术后常见的一种远期并发症，其发病与切口缝合方法、术后感染等因素有关，临床表现为术后经期延长、慢性下腹痛、性交后出血等［1］。
临床医学China &Foreign Medical Treatment 中外医疗子宫内膜息肉给予宫腔镜息肉电切术辅以左炔诺孕酮宫内缓释系统的疗效分析张丽艳，孙爽长春中医药大学附属医院妇产诊疗中心，吉林长春 130021［摘要］ 目的 观察在子宫内膜息肉的治疗当中在给予宫腔镜息肉电切术之后辅助使用左炔诺孕酮宫内缓释系统治的效果。
方法 便利选取2022年1月—2023年2月长春中医药大学附属医院收治的98例子宫内膜息肉患者。
按随机数表法分为两组，各49例。
对照组采用宫腔镜息肉电切术治疗，观察组在对照组基础上辅以左炔诺孕酮宫内缓释系统。
对比治疗后腺上皮及间质雌激素受体、腺上皮及间质孕激素受体、血清指标、复发率等。
结果 观察组术后1个月月经量更少、血红蛋白水平上升，且观察组术后3及6个月其子宫内膜厚度及月经量少于对照组，血红蛋白水平高于对照组，差异有统计学意义（P <0.05）；治疗后观察组腺上皮及间质雌激素受体、腺上皮及间质孕激素受体、血清指标水平均低于对照组，差异有统计学意义（P <0.05）；观察组的复发率为4.08%，低于对照组的16.33%，差异有统计学意义（χ2=4.455，P <0.05）。
结论 在子宫内膜息肉的患者的宫腔镜息肉电切术之后辅以左炔诺孕酮宫内缓释系统治疗，能够使原本较厚的子宫内膜变薄，并减少原本过多的月经量，恢复血红蛋白及血清糖类抗原125、高敏C 反应蛋白、血管内皮生长因子水平，调节雌激素及孕激素受体表达平衡，降低复发率，且具有良好的治疗安全性。
［关键词］ 子宫内膜息肉；宫腔镜；息肉电切术；左炔诺孕酮宫内缓释系统；子宫内膜厚度；月经量［中图分类号］ R713 ［文献标识码］ A ［文章编号］ 1674-0742（2023）11(b)-0059-04Efficacy of Hysteroscopic Electropolypectomy Combined with Levonorg⁃estrel Intrauterine Sustained Release System for Endometrial PolypsZHANG Liyan, SUN ShuangDepartment of Obstetrics and Gynecology Diagnosis and Treatment Center, the Affiliated Hospital of Changchun Uni⁃versity of Chinese Medicine, Changchun, Jilin Province, 130021 China[Abstract] Objective To observe the effect of levonorgestrel intrauterine sustained release system after hysteroscopic electropolypectomy in the treatment of endometrial polyps. Methods A total of 98 patients with endometrial polyps ad⁃mitted to the Affiliated Hospital of Changchun University of Traditional Chinese Medicine from January 2022 to Febru⁃ary 2023 were conveniently selected. According to the random number table method, they were divided into twogroups, 49 cases in each group. The control group was treated with hysteroscopic polyp resection, and the observationgroup was supplemented with levonorgestrel intrauterine sustained-release system on the basis of the control group. The glandular epithelial and stromal estrogen receptors, glandular epithelial and stromal progesterone receptors, serum indexes, and recurrence rate were compared after treatment. Results The menstrual volume of the observation group was lower and the hemoglobin level was higher 1 month after operation, and the endometrial thickness and menstrualvolume of the observation group were less than those of the control group 3 and 6 months after operation, and the he⁃moglobin level were higher than that of the control group, and the differences were statistically significant (P <0.05) af⁃ter treatment, the levels of estrogen receptor in glandular epithelium and stroma, progesterone receptor in glandularepithelium and stroma, and serum indexes in the observation were all lower than those in the control group, and the differences were statistically significant (P <0.05), the recurrence rate of the observation group was 4.08%, which was DOI ：10.16662/ki.1674-0742.2023.32.059[作者简介] 张丽艳（1989-），女，硕士，住院医师，研究方向为妇产科学临床研究。
观察宫腔镜子宫内膜息肉切除术后应用左炔诺孕酮宫内缓释系统对预防子宫内膜息肉术后复发的临床效果摘要：目的：观察左炔诺孕酮在预防宫腔镜子宫内膜息肉切除术后复发中的应用效果。
方法：选择2016年10月-2017年12月期间在我院接受治疗的子宫内膜息肉患者52例作为研究对象，随机划入观察组和对照组，其中观察组26例，对照组26例，分别接受左炔诺孕酮宫内缓释和常规处理，比较两组患者的术后复发率、PBAC评分、子宫内膜厚度、月经量以及不良反应发生例数。
结果：观察组患者PBCA评分52.5±4.3分，子宫内膜厚度0.7±0.2mm，月经量78.6±3.5ml，息肉复发2例；对照组患者PBCA评分36.2±5.8分，子宫内膜厚度0.9±0.3mm，月经量42.4±4.7ml，息肉复发8例；组间差异有统计学意义，P＜0.05。
观察组患者26例，阴道异常出血0例，乳房胀痛1例，体重增加0例，总计1例；对照组患者26例，阴道异常出血2例，乳房胀痛3例，体重2例；总计7例；组间差异有统计学意义，P＜0.05。
结论：左炔诺孕酮宫内缓释在预防宫腔镜子宫内膜息肉切除术术后复发中的应用效果显著，值得临床应用和推广。
关键词：宫腔镜子宫内膜息肉切除术；左炔诺孕酮；子宫内膜息肉[abstract] objective：to observe the effect of levonogesterone in the preventionof hysteroscopic recurrence after endometrial polypectomy. Methods：in October 2016 - December 2017 treated in our hospital during the period of 52 patients with endometrial polyps as the research object，randomly into observation group and control group，the observation group of 26 cases，the control group，26 cases were underwent left acetylene connaught progesterone intrauterine slow-release and conventional treatment，compared two groups of patients with postoperative recurrence rate，the PBAC score，endometrial thickness，menstrual quantity and cases of adverse reactions occur. Results：the PBCA score of the observation group was 52.5 plus or minus 4.3，the endometrial thickness was 0.70.2mm，the menstrual volume was 78.6 plus or minus 3.5ml，and the recurrence of polyps was 2. In the control group，PBCA scores 36.2 + 5.8 points，endometrium thickness 0.9 + 0.3mm，menstrual volume 42.4，plus or minus 4.7 ml，and 8 cases of polyp recurrence；The difference between groups was statistically significant，P < 0.05. There were 26 patients in the observation group，0 cases of abnormal vaginal bleeding，1 case of breast distend，and 0 cases of weight gain. In the control group，there were 26 cases，2 cases of abnormal vaginal bleeding，3 cases of breast distended and 2 cases of weight. A total of 7 cases；The difference between groups was statistically significant，P < 0.05. Conclusion：the application of levonogesterone intrauterine in the prevention of hysteroscopic endometrial polypectomy is significant and worthy of clinical application and promotion.[key words] hysteroscopic endometriectomy；Levonogesterone；Endometrium polyp为了观察左炔诺孕酮在预防宫腔镜子宫内膜息肉切除术后复发中的应用效果，选择2016年10月-2017年12月期间在我院接受治疗的子宫内膜息肉患者52例作为研究对象进行临床研究，现报道如下。
左炔诺孕酮宫内缓释系统治疗子宫内膜异位症及子宫腺肌病的5年临床观察李晓红;杜蓉;丁岩【期刊名称】《实用医学杂志》【年(卷),期】2014(000)012【摘要】目的：观察左炔诺孕酮宫内缓释系统（levonorgestrel intrauterine system，LNG-IUS）治疗子宫内膜异位症（endometriosis， EM）及子宫腺肌病（adenomyosis， AM）的5年疗效。
方法：对49例诊断为 EM 或 AM的患者放置 LNG-IUS ，观察放置前、放置后6、12、36个月及60个月的痛经评分、子宫体积、子宫内膜厚度等指标。
结果：与放置 LNG-IUS 前相比，49例患者在放环60个月后痛经、性交痛、慢性盆腔痛评分、月经失血量、CA125水平、子宫体积、子宫内膜厚度均明显下降，血红蛋白值显著升高，差异均有统计学意义（P ＜0．05），盆腔囊肿体积无统计学差异（P ＞0．05）。
各项观察指标在随访60个月内变化趋势不相同。
结论：LNG-IUS可有效缓解EM及AM疼痛，减少月经失血量，其5年疗效值得肯定。
【总页数】3页(P1938-1940)【作者】李晓红;杜蓉;丁岩【作者单位】830054 乌鲁木齐市，新疆医科大学第一附属医院妇科;830054 乌鲁木齐市，新疆医科大学第一附属医院妇科;830054 乌鲁木齐市，新疆医科大学第一附属医院妇科【正文语种】中文【相关文献】1.左炔诺孕酮宫内缓释系统治疗阴道直肠隔子宫内膜异位症临床观察 [J], 张琳2.左炔诺孕酮宫内缓释系统治疗子宫内膜异位症17例临床观察 [J], 卢红3.左炔诺孕酮宫内缓释系统治疗子宫内膜异位症及子宫腺肌病临床分析 [J], 易姗祺;胡红波;罗萍香;胡卫忠;李广敏;丁颂4.宫腔镜子宫内膜切除联合左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J], 朱冰鸥5.左炔诺孕酮宫内缓释系统治疗阴道直肠隔子宫内膜异位症的临床观察 [J], 宋楠;冷金花因版权原因，仅展示原文概要，查看原文内容请购买。
